Danielle Baum

1.5k citations
16 papers · 842 · 1 hit paper · h-index 10

Impact in

Papers in

    • Immunotherapy and Immune Responses 3
    • T-cell and B-cell Immunology 2
    • Dermatology and Skin Diseases 2
    • Cutaneous lymphoproliferative disorders research 2

Danielle Baum

16 papers receiving 810 citations

Danielle Baum's Hit Papers

Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial 2018 · 265 citations
2650+2+5Years since publication50100150200250

Peers

Danielle Baum
Comparison fields: 5 of 82
  • Dermatology 279
  • Immunology and Allergy 126
  • Immunology 383
  • Urology 40
  • Rheumatology 78
Replace Caroline Mills with:
Caroline Mills United Kingdom
V. Sigurdsson Netherlands
John Hunter United Kingdom
Trevor Markham Ireland
Claudio Bonifati Italy
Ligia Brzeźińska-Wcisło Poland
Gary Tran United States
L. Manolache Ukraine
P.M. McHenry United Kingdom
Danielle Baum relative to Caroline Mills United Kingdom Caroline Mills's profile →
Citations per field
00.5×4.4×
Caroline Mills · 1×
Citations per year

Countries citing papers authored by Danielle Baum

Since Specialization
Citations

This map shows the geographic impact of Danielle Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Baum more than expected).

Fields of papers citing papers by Danielle Baum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Baum. The network helps show where Danielle Baum may publish in the future.

Co-authors

The 25 scholars most cited alongside Danielle Baum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Danielle Baum Line = papers co-authored together Danielle Baum links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
Hit paper breakdown →
2018265
2 2017152
3 2018136
4 198668
5 201852
6 201849
7 201936
8 202131
9 202128
10 202210
11 19856
12 20154
13 19872
14 20171
15 20191
16 20181

About Danielle Baum

Danielle Baum is a scholar working on Immunology, Dermatology, Genetics, Surgery and Molecular Biology, having authored 16 papers that have together received 842 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Diabetes and associated disorders (3 papers), T-cell and B-cell Immunology (2 papers), Dermatology and Skin Diseases (2 papers), Cutaneous lymphoproliferative disorders research (2 papers), Pancreatic function and diabetes (2 papers), CAR-T cell therapy research (2 papers) and Pharmaceutical studies and practices (1 paper). The work is most often cited by research in Dermatology (279 citations), Immunology and Allergy (126 citations), Immunology (383 citations), Urology (40 citations) and Rheumatology (78 citations). Danielle Baum has collaborated with scholars based in United States, Italy and Switzerland. Frequent co-authors include Thomas L. Creer, Audrey Defusco, Giselle Singer, Daniel Huang, Mark Lebwohl, Denise L. Faustman, Ana B. Pavel, Emma Guttman‐Yassky, Lisa Tran and Heather Torrey. Their work appears in journals such as Archives of Dermatological Research, Clinical Gerontologist, Journal of the American Academy of Dermatology, JCI Insight and npj Vaccines.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact